मूलभूत आँकड़े
CIK | 727346 |
SEC Filings
SEC Filings (Chronological Order)
August 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Registr |
|
July 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2025 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe |
|
June 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2025 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe |
|
May 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist |
|
May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: March 31, 2025 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Reg |
|
April 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist |
|
March 31, 2025 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q ☐ Form N-SAR For Period Ended: December 31, 2024 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Registran |
|
February 13, 2025 |
Purchase and Sale Agreement – Sparta Facility Exhibit 10.2 PURCHASE AND SALE AGREEMENT by and between Providence HR, LLC (“Seller”), and Sparta Propco Holdco LLC (“Purchaser”) February 7, 2025 PURCHASE AND SALE AGREEMENT This PURCHASE AND SALE AGREEMENT (this “Agreement”), dated effective as of February 7, 2025 (the “Effective Date”), is by and between Providence HR, LLC, a Georgia limited liability company (“Seller”), and Sparta Propco Holdc |
|
February 13, 2025 |
Purchase and Sale Agreement – Glen Eagle, Eastman and Warrenton Facilities Exhibit 10.1 PURCHASE AND SALE AGREEMENT by and between Global Abbeville Property, LLC Dodge NH, LLC Atl/Warr, LLC (collectively, “Seller”), and Abbeville Propco Holdco LLC (“Purchaser”) February 7, 2025 PURCHASE AND SALE AGREEMENT This PURCHASE AND SALE AGREEMENT (this “Agreement”), dated effective as of February 7, 2025 (the “Effective Date”), is by and between Global Abbeville Property, LLC, Do |
|
February 13, 2025 |
Operations Transfer Agreement -Glen Eagle, Eastman and Warrenton Facilities Exhibit 10.3 OPERATIONS TRANSFER AGREEMENT THIS OPERATIONS TRANSFER AGREEMENT (“Agreement”) made effective as of February 7, 2025 (the “Effective Date”) is entered into by and among Global Abbeville, LLC, Global Eastman, LLC, and Selectis Warrenton, LLC, each a Georgia limited liability company (collectively, the “Existing Operator” or “Operator”) and Abbeville Opco Holdco LLC, a Delaware limited |
|
February 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2025 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu |
|
February 13, 2025 |
Exhibit 10.5 DEPOSIT ESCROW AGREEMENT THIS DEPOSIT ESCROW AGREEMENT dated February 7, 2025 is made by and among Global Abbeville Property, LLC, Dodge NH, LLC and Atl/Warr, LLC, each a Georgia limited liability company (individually and collectively, “Seller”), Abbeville Propco Holdco LLC, a Delaware limited liability company (individually and collectively, “Purchaser”), and Landmark Abstract Agenc |
|
February 13, 2025 |
Operations Transfer Agreement – Sparta Facility Exhibit 10.4 OPERATIONS TRANSFER AGREEMENT THIS OPERATIONS TRANSFER AGREEMENT (“Agreement”) made effective as of February 7, 2025 (the “Effective Date”) is entered into by and among Selectis Sparta, LLC, a Georgia limited liability company (the “Existing Operator” or “Operator”) and Sparta Opco Holdco LLC, a Delaware limited liability company (the “New Operator” and together with the Existing Oper |
|
January 23, 2025 |
Separation Agreement and Release Exhibit 10.1 |
|
January 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2025 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu |
|
December 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu |
|
November 22, 2024 |
Exhibit 16.1 |
|
November 22, 2024 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2024. SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission File (I.R.S. Employer o |
|
November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Re |
|
October 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A-1 ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Re |
|
October 4, 2024 |
8480 E. Orchard Rd, Ste 4900 Greenwood Village, CO 80111 8480 E. Orchard Rd, Ste 4900 Greenwood Village, CO 80111 Via Edgar Filing October 4, 2024 Kellie Kim Division of Corporation Finance US Securities and Exchange Commission Washington, DC Re: Selectis Health, Inc. Form 10-K for the year ended December 31,2023 Filed April 16, 2024 File No. 000-15415 Ladies and Gentlemen: Please accept the following in response to the comments of the Commission dated |
|
October 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Num |
|
August 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Num |
|
August 29, 2024 |
Exhibit 10.1 |
|
August 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Registr |
|
August 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25/A-1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25/A-1 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: June 30, 2024 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I— |
|
August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: June 30, 2024 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Regi |
|
July 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe |
|
June 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe |
|
May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist |
|
May 9, 2024 |
- Archway Nursing Facility and Related Property to be Sold for $6.75 Million - Exhibit 99.1 Selectis Health Enters Definitive Purchase and Sale Agreement for Archway Transitional Care Center in Georgia - Archway Nursing Facility and Related Property to be Sold for $6.75 Million - Greenwood Village, Colorado, May 9, 2024 – Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) announced that its wholly-owned subsidiary, Goodwill Hunting, LLC (the “Seller”), has execu |
|
May 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number |
|
May 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number |
|
May 8, 2024 |
Exhibits 10.1 |
|
April 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numb |
|
April 23, 2024 |
Commercial Line of Credit Agreement and Note Exhibit 10.1 |
|
April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist |
|
April 1, 2024 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q ☐ Form N-SAR For Period Ended: December 31, 2023 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Registran |
|
March 25, 2024 |
Exhibit 10.1 INDEMNITY AGREEMENT This Indemnity Agreement (this “Agreement”), dated as of , 202, is made by and between SELECTIS HEALTH, INC., a Utah corporation (the “Company”), and, a director and/or officer of the Company (the “Indemnitee”). RECITALS A. The Company is aware that competent and experienced persons are increasingly reluctant to serve as directors or officers of corporations unless |
|
March 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numb |
|
March 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numb |
|
February 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N |
|
December 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2023 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N |
|
December 22, 2023 |
Exhibit 99.1 Selectis Health Makes Key Leadership Appointments Jim Creamer Appointed as Interim Chief Financial Officer Clifford Neuman Appointed to Board of Directors Greenwood Village, CO – December 19, 2023 – Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) has appointed Jim Creamer as Interim Chief Financial Officer and Clifford Neuman to its board of directors. Creamer’s appoin |
|
December 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2023 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N |
|
December 5, 2023 |
Exhibit 10.2 EXECUTION COUNTERPART OPERATIONS TRANSFER AGREEMENT THIS OPERATIONS TRANSFER AGREEMENT (“Agreement”) dated as of November 30, 2023 (the “Effective Date”) is by and Global Abbeville, LLC, a Georgia limited liability company, Global Eastman, LLC, a Georgia limited liability company, Selectis Sparta, LLC, a Georgia limited liability company, and Selectis Warrenton, LLC, a Georgia limited |
|
December 5, 2023 |
Exhibit 99.1 Selectis Health Enters Agreements to Sell Four Skilled Nursing Facilities in Georgia - The Company’s Warrenton, Eastman, Glen Eagle, and Sparta Facilities to be Acquired for an Aggregate Consideration of $31 Million - Greenwood Village, Colorado, December 5, 2023 – Selectis Health, Inc. (OTC: GBCS) (“Selectis” or the “Company”) announced that several wholly owned affiliates (the “Affi |
|
December 5, 2023 |
Exhibit 10.1 Execution Counterpart PURCHASE AND SALE AGREEMENT by and between Global Abbeville Property, LLC Dodge NH, LLC Providence HR, LLC Atl/Warr, LLC (collectively, “Seller”), and Glen Eagle Propco LLC Eastman Propco LLC Providence Propco LLC Warrenton Propco LLC (collectively “Purchaser”) November 30, 2023 PURCHASE AND SALE AGREEMENT This PURCHASE AND SALE AGREEMENT (this “Agreement”), date |
|
November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Re |
|
November 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2023 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu |
|
September 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Registr |
|
August 8, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: June 30, 2023 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Registrant In |
|
August 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist |
|
June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist |
|
May 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2023 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number |
|
May 16, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: March 31, 2023 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Registrant I |
|
March 31, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q ☐ Form N-SAR For Period Ended: December 31, 2022 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Registran |
|
March 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2023 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe |
|
January 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Re |
|
December 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu |
|
November 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N |
|
November 16, 2022 |
November 2022 Investor Presentation. Exhibit 99.1 |
|
November 14, 2022 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NT 10-Q 1 formnt10-q.htm U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: September 30, 2022 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification rel |
|
October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu |
|
October 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission FileNum |
|
October 26, 2022 |
October, 2022 Investor Presentation. Exhibit 99.1 |
|
October 20, 2022 |
DEF 14A 1 formdef14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule |
|
October 20, 2022 |
Exhibit 99.1 Selectis Health Appoints Andrew Sink to Board of Directors - Company Concurrently Announces Resignation of Clifford Neuman as Director and Secretary - - Sink?s Appointment as Independent Director Fulfills Remaining Corporate Governance Requirements for Major National Exchange Listing - Greenwood Village, CO ? October 18, 2022 ? Selectis Health, Inc. (OTC: GBCS) (?Selectis? or the ?Com |
|
October 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer of incor |
|
October 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu |
|
October 5, 2022 |
Exhibit 16.1 |
|
October 5, 2022 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission File (I.R.S. Employer of i |
|
September 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File |
|
September 20, 2022 |
Exhibit 99.1 Selectis Health Reports First Half 2022 Results and Provides Business Update - First Quarter and Second Quarter 10-Q Filings Allow the Company to Regain Compliance with SEC Reporting Obligations - - Q2 2022 Revenue Increases 91% Year-over-Year to a Record $11.5 Million - - Q2 2022 Net Income Increases Significantly to Over $1.0 Million - Greenwood Village, Colorado, September 19, 2022 |
|
September 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist |
|
September 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Registr |
|
August 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Regist |
|
August 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Num |
|
July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe |
|
July 29, 2022 |
Exhibit 10.6 SELECTIS HEALTH, INC. Whistleblower Policy Procedures for the Submission of Complaints or Concerns regarding Financial Statement or other Disclosures, Accounting, Internal Accounting or Disclosure Controls, Auditing Matters or violations of the Selectis Health, Inc. Code of Business Conduct and Ethics. Section 301 of the Sarbanes-Oxley Act requires the Audit Committee of the Board of |
|
July 29, 2022 |
Nominating and Governance Committee Charter Exhibit 10.2 SELECTIS HEALTH, INC. NOMINATING AND GOVERNANCE COMMITTEE CHARTER As adopted by the Nominating and Governance Committee and Board of Directors on July 25, 2022 I. PURPOSE The primary purpose of the Nominating and Governance Committee (the ?Committee?) of the Board of Directors (the ?Board?) of Selectis Health, Inc., (the ?Company?) shall be to act on behalf of the Board in fulfilling |
|
July 29, 2022 |
Exhibit 10.1 SELECTIS HEALTH, INC. AUDIT COMMITTEE CHARTER As adopted by the Audit Committee and Board of Directors on July 25, 2022 I. RESPONSIBILITY The Selectis Health, Inc.?s (?Selectis?) Audit Committee (?Committee?) was established to assist the Board of Directors (the ?Board?) in carrying out its oversight compliance with laws responsibilities that relate to Selectis? accounting and financi |
|
July 29, 2022 |
Code of Conduct and Ethics Policy Exhibit 10.4 SELECTIS HEALTH, INC. CODE OF BUSINESS CONDUCT AND ETHICS Adopted as of July 25, 2022 Introduction This Code of Business Conduct and Ethics (the ?Code?) applies to Selectis Health, Inc. (?Selectis? or the ?Company?). This Code covers a wide range of business practices and procedures. The Code should also be provided to and followed by the Company?s agents and representatives, includin |
|
July 29, 2022 |
Exhibit 10.5 SELECTIS HEALTH, INC. DOCUMENT RETENTION POLICY The corporate records of Selectis Health, Inc., a Delaware corporation (hereafter the ?Company?) are important assets. Corporate records include essentially all records you produce as an employee, whether paper or electronic. A record may be as obvious as a memorandum, an e-mail, a contract or a case study, or something not as obvious, s |
|
July 29, 2022 |
Compensation Committee Charter Exhibit 10.3 SELECTIS HEALTH, INC. COMPENSATION COMMITTEE CHARTER As adopted by the Compensation Committee and Board of Directors on July 25, 2022 Purpose The Compensation Committee (the ?Committee?) exists to assist the Board of Directors in the discharge of its fiduciary responsibilities relating to the fair and competitive compensation of the executives and other key employees of the Company. T |
|
July 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number |
|
May 17, 2022 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NT 10-Q 1 formnt10-q.htm U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR For Period Ended: March 31, 2022 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates |
|
April 4, 2022 |
Non-Statutory Stock Option Agreement- Barker Exhibit 10.2 SELECTIS HEALTH, INC. NON-STATUTORY STOCK OPTION AGREEMENT This Non-Statutory Stock Option Agreement (the ?Agreement?) is made and entered into effective the 30th day of March, 2022, between Selectis Health, Inc. (the ?Company?) and Christopher Barker (?Optionee?). NOW, THEREFORE, it is hereby agreed as follows: 1. Grant of Option. The Company hereby grants to Optionee, as of the date |
|
April 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numb |
|
April 4, 2022 |
Non-Statutory Stock Option Agreement - Baller Exhibit 10.1 SELECTIS HEALTH, INC. NON-STATUTORY STOCK OPTION AGREEMENT This Non-Statutory Stock Option Agreement (the ?Agreement?) is made and entered into effective the 30th day of March, 2022, between Selectis Health, Inc. (the ?Company?) and Lance Baller (?Optionee?). NOW, THEREFORE, it is hereby agreed as follows: 1. Grant of Option. The Company hereby grants to Optionee, as of the date hereo |
|
March 29, 2022 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NT 10-K 1 formnt10-k.htm U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 816291108 NOTICE OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 11-K ☐ Form 20-F ☐ Form 10-Q ☐ Form N-SAR For Period Ended: December 31, 2021 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification rela |
|
March 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Numbe |
|
January 28, 2022 |
Exhibit 16.1 |
|
January 28, 2022 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Nu |
|
January 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A-1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File |
|
January 12, 2022 |
Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Num |
|
January 12, 2022 |
Financial Public Investor Relations Agreement Exhibit 99.1 |
|
January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2022 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Num |
|
January 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A-1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
January 3, 2022 |
Exhibit 4.4 |
|
December 30, 2021 |
Exhibit 4.3 |
|
December 30, 2021 |
Deferred Compensation and Equity Award Plan Exhibit 4.1 SELECTIS HEALTH, INC. DEFERRED COMPENSATION AND EQUITY AWARD PLAN Effective on July 1, 2021 1. Purpose. (a) Selectis Health, Inc. (?Selectis?) has established this Deferred Compensation and Equity Award Plan (the ?Plan? ). (b) The purpose of the Plan is to enable officers, directors and key employees (?Eligible Persons?) to defer receipt of compensation for their services on behalf of |
|
December 30, 2021 |
Exhibit 4.2 |
|
December 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N |
|
November 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N |
|
November 17, 2021 |
SUMMARY OF THIRD QUARTER RESULTS SELECTIS HEALTH, INC. CONSOLIDATED BALANCE SHEETS Exhibit 99.1 Selectis Health Reports Third Quarter 2021 Financial Results Greenwood Village, Colorado, November 16, 2021 ? Selectis Health, Inc. (OTC: GBCS) (?Selectis? or the ?Company?) today reported a Net Loss for the three months ended September 30, 2021, of $0.06 million, or a net loss of $0.02 per diluted share. Total revenue increased to $7.32 million for the third quarter of 2021 compared |
|
November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File N |
|
November 15, 2021 |
Exhinit 99.1 Selectis Health Schedules Third Quarter Earnings Call for Tuesday, November 16, 2021 Greenwood Village, Colorado, November 12, 2021 ? Selectis Health, Inc. (OTC: GBCS) (?Selectis? or the ?Company?), announced today that it expects to issue its third quarter 2021 financial results on November 16, 2021. Conference Call Selectis invites current and prospective investors to join the share |
|
November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 Selectis Health, Inc. (Exact name of Re |
|
November 4, 2021 |
November, 2021 Investor Presentation. Exhibit 99.1 |
|
November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission FileNum |
|
October 4, 2021 |
Exhibit 10.2 |
|
October 4, 2021 |
Selectis Health Announces Refinance, Renovation, and new Executive Director of Southern Hills Campus Exhibit 99.1 Selectis Health Announces Refinance, Renovation, and new Executive Director of Southern Hills Campus GREENWOOD VILLAGE, Colorado, September 28, 2021 ? Selectis Health, Inc. (the ?Company? or ?Selectis?), (OTC: GBCSD) announced today that it successfully refinanced the mortgage on the Southern Hills Continuing Care Retirement Community (?CCRC?) after completing several renovations, and |
|
October 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 27, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File |
|
October 4, 2021 |
Healthcare Mortgage, Assignment of Leases and Rents and Security Agreement Exhibit 10.1 |
|
September 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File |
|
September 22, 2021 |
Amendment No. 1 to Second Amended and Restated Articles of Incorporation Exhibit 10.1 AMENDMENT NO. 1 TO SECOND AMENDMENT AND RESTATED ARTICLES OF INCORPORATION OF SELECTIS HEALTH, INC. (formerly Global Healthcare REIT, Inc.) Pursuant to the Utah Business Corporation Act, (the ?Act?) the undersigned being the President and Secretary of Selectis Health, Inc., formerly Global Healthcare REIT, Inc. (the ?Company? or the ?Corporation?) hereby affirm that the following Amen |
|
September 22, 2021 |
Selectis Health Announces Effective Date of Reverse Stock Split and Name Change Exhibit 99.1 Selectis Health Announces Effective Date of Reverse Stock Split and Name Change Common Stock Will Begin Trading with its new name and on a Split-Adjusted Basis on September 22, 2021 GREENWOOD VILLAGE, Colorado, September 21, 2021 ? Selectis Health, Inc. (formerly Global Healthcare REIT, Inc.) (the ?Company? or ?Selectis?), announced today that it intends to effect a reverse stock spli |
|
September 9, 2021 |
GBCS / Global Healthcare REIT Inc / Baller Lance Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A-4 Under the Securities Exchange Act of 1934 (Amendment No. 4)* SELECTIS HEALTH, INC., f/k/a GLOBAL HEALTHCARE REIT, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 37953J 10 7 (CUSIP Number) Clifford L. Neuman, PC 6800 N. 79th Street, Suite 200 Niwot, Colorado 80503 (303) 449 – 2100 (Name, Addr |
|
August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 SELECTIS HEALTH, INC. f/k/a GLOBAL HEALTHCAR |
|
July 14, 2021 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 9, 2021 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number |
|
June 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2021 SELECTIS HEALTH, INC. f/k/a Global Healthcare REIT, Inc. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of i |
|
May 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File |
|
May 26, 2021 |
Exhibit 99.1 Updated: Selectis Health Reports First Quarter 2021 Financial Results Greenwood Village, Colorado, May 20, 2021 (GLOBE NEWSWIRE) ? Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) (?Selectis? or the ?Company?) today reported net income for the first quarter of 2021 of $240,566, or $0.01 per diluted share. Total revenue increased 49.6 |
|
May 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File |
|
May 20, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact nam |
|
May 17, 2021 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ x ] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2021 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I? |
|
April 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 2, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer of i |
|
April 9, 2021 |
Exhibit 99.1 Selectis Health Reports Fourth Quarter and Year-End 2020 Financial Results Greenwood Village, Colorado, March. 31, 2021 – Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) ("Selectis" or the "Company") today reported net income for the fourth quarter of 2020 of $1.3 million, or $0.05 per diluted share, and $2.93 million, or $.11 per d |
|
April 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X] Def |
|
March 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):March 30, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer of |
|
March 31, 2021 |
Exhibit 99.1 Selectis Health Announces the Reopening of Renovated Oklahoma City Facility and 2020 Financial Results Conference Call Greenwood Village, Colorado, March 30, 2021 – Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) is pleased to announce that it was granted its Nursing Facility License by the Oklahoma Sta |
|
March 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact nam |
|
March 30, 2021 |
EX-99.1 2 ex99-1.htm Exhibit 99.1 Selectis Health Announces the Reopening of Renovated Oklahoma City Facility and 2020 Financial Results Conference Call Greenwood Village, Colorado, March 30, 2021 – Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) is pleased to announce that it was granted its Nursing Facility Licens |
|
March 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer of |
|
March 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [X] Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Def |
|
January 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
January 6, 2021 |
Selectis Health Announces the Completion of Oklahoma Fairlands Skilled Nursing Facility Purchase Exhibit 99.1 Selectis Health Announces the Completion of Oklahoma Fairlands Skilled Nursing Facility Purchase Niwot, Colorado., January 4, 2021 – Global Healthcare REIT, Inc. (Currently in a rebranding effort to Selectis Health, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) is pleased to announce that, through its newly formed wholly-owned subsidiary Global Fairland Property, LLC (“Fairland Prop |
|
January 6, 2021 |
Exhibit 10.2 |
|
January 6, 2021 |
Regulation FD Disclosure, 8-K, 8-K, 8-K, 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 31, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
January 6, 2021 |
EX-10.1 2 ex10-1.htm Exhibit 10.1 |
|
January 6, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission F |
|
January 5, 2021 |
Selectis Health Appoints President and Chief Operating Officer EX-99.1 2 ex99-1.htm Exhibit 99.1 Selectis Health Appoints President and Chief Operating Officer Greenwood Village, Colorado, January 5, 2021 (GLOBE NEWSWIRE) —Global Healthcare REIT, Inc. (Currently in a rebranding effort to be renamed Selectis Health, Inc.) (OTC: GBCS) (“Selectis” or the “Company”) an owner and operator of healthcare facilities in AR, GA, OH, and OK today announced that Randy Ba |
|
January 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2021 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission F |
|
December 31, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact |
|
December 2, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
November 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
November 19, 2020 |
GLOBAL HEALTHCARE REIT, INC. CONSOLIDATED BALANCE SHEETS Exhibit 99.1 Global Healthcare Announces 2nd Quarter 2020 Results Niwot, Colorado., Nov. 19 , 2020 ? Global Healthcare REIT, Inc. (OTC: GBCS) (?Global? or the ?Company?) announced financial results for the second quarter ended June 30, 2020. SECOND QUARTER 2020 HIGHLIGHTS ? Record revenue for the second quarter of $5,130,465 (2019 $1,614,424) a growth rate of 217% year-over -year and up 33% from t |
|
November 18, 2020 |
10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE RE |
|
October 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact nam |
|
October 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commissio |
|
August 24, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission F |
|
August 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
July 27, 2020 |
Exhibit 10.1 ASSET PURCHASE AGREEMENT by and between TG OPERATIONS, LLC An Oklahoma Limited Liability Company as Seller, and GLOBAL FAIRLAND PROPERTY, LLC, An Oklahoma Limited Liability Company, as Purchaser July 23, 2020 TABLE OF CONTENTS PAGE 1. PURCHASE AND SALE 1 2. TRANSFER OF OPERATIONS. 2 3. THE PROPERTY. 2 4. EXCLUDED PROPERTY 2 5. CLOSING 2 6. PURCHASE PRICE. 3 7. EXPENSES. 3 8. PRORATION |
|
July 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fil |
|
July 10, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC . (Exact na |
|
May 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
May 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File |
|
May 13, 2020 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2019 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I |
|
May 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File |
|
April 28, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 20, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
March 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
March 5, 2020 |
EX-10.2 3 ex10-2.htm Exhibit 10.2 |
|
March 5, 2020 |
Exhibit 10.6 |
|
March 5, 2020 |
EX-10.5 6 ex10-5.htm Exhibit 10.5 |
|
March 5, 2020 |
8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporati |
|
March 5, 2020 |
Exhibit 10.4 |
|
March 5, 2020 |
Form of Mortgage, Security Agreement and Assignment of Rents EX-10.3 4 ex10-3.htm Exhibit 10.3 |
|
March 5, 2020 |
Exhibit 10.1 |
|
February 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2020 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
December 3, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
November 19, 2019 | ||
November 19, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
November 18, 2019 |
GBCS / Global Healthcare REIT, Inc. 10-Q - Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact |
|
November 15, 2019 |
GBCS / Global Healthcare REIT, Inc. NT 10-Q - - U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-CEN For Period Ended: September 30, 2019 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part |
|
November 15, 2019 |
GBCS / Global Healthcare REIT, Inc. / Rhine Zvi Michael Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A-1 Under the Securities Exchange Act of 1934 (Amendment No. 1)* GLOBAL HEALTHCARE REIT, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 37953J 10 7 (CUSIP Number) Clifford L. Neuman, PC 6800 N. 79th Street, Suite 200 Niwot, Colorado 80503 (303) 449 – 2100 (Name, Address, and Telephone Number of |
|
October 23, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
September 24, 2019 |
8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorp |
|
August 19, 2019 |
GBCS / Global Healthcare REIT, Inc. 10-Q - Quarterly Report - 10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE RE |
|
August 14, 2019 |
GBCS / Global Healthcare REIT, Inc. NT 10-Q - - NT 10-Q 1 formnt10-q.htm U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-CEN For Period Ended: June 30, 2019 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notificatio |
|
August 13, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
August 13, 2019 |
Loan Document Purchase and Assignment Agreement EX-10.1 2 ex10-1.htm LOAN DOCUMENT PURCHASE AND ASSIGNMENT AGREEMENT THIS LOAN DOCUMENT PURCHASE AND ASSIGNMENT AGREEMENT (the “Agreement”), is effective this 26th day of July, 2019 (the “Effective Date”), by and between F&M BANK (“Assignor” or “Seller”) and GLOBAL HEALTHCARE REIT, INC., a Utah corporation (“Assignee” or “Buyer”). RECITALS A. Assignor is a party to certain loan documents which evi |
|
July 11, 2019 |
EX-10.1 2 ex10-1.htm |
|
July 11, 2019 |
8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporati |
|
June 5, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File |
|
May 20, 2019 |
GBCS / Global Healthcare REIT, Inc. 10-Q - Quarterly Report - 10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE R |
|
May 15, 2019 |
GBCS / Global Healthcare REIT, Inc. NT 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2019 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Re |
|
April 17, 2019 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
April 17, 2019 |
Amendment No. 1 to Employment Agreement AMENDMENT NO. I TO EMPLOYMENT AGREEMENT This Amendment No. I to Employment Agreement dated May 4, 2018 is made and entered into effective the 1st day of April, 2019 by and between Global Healthcare REIT, Inc. (the “Company”) and Zvi Rhine (“Employee”). RECITALS A. Employee and the Company entered into an Employment Agreement dated May 4, 2018, to be effective January 1, 2018 (the “Employment Agree |
|
April 16, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
April 16, 2019 |
EX-10.1 2 ex10-1.htm |
|
April 16, 2019 |
GBCS / Global Healthcare REIT, Inc. (Annual Report) 10-K 1 form10-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE R |
|
April 1, 2019 |
GBCS / Global Healthcare REIT, Inc. U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2018 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part |
|
March 7, 2019 |
GBCS / Global Healthcare REIT, Inc. / Baller Lance Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A-3 Under the Securities Exchange Act of 1934 (Amendment No. 3)* GLOBAL HEALTHCARE REIT, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 37953J 10 7 (CUSIP Number) Clifford L. Neuman, PC 6800 N. 79th Street, Suite 200 Niwot, Colorado 80503 (303) 449 – 2100 (Name, Address, and Telephone Number of |
|
February 26, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2019 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
December 4, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
November 19, 2018 |
GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact |
|
November 13, 2018 |
GBCS / Global Healthcare REIT, Inc. NT 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ x ] Form 10-Q [ ] Form N-SAR For Period Ended: September 30, 2018 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Par |
|
November 8, 2018 |
8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorpor |
|
October 22, 2018 | ||
October 22, 2018 |
8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission |
|
October 10, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission F |
|
September 14, 2018 |
GBCS / Global Healthcare REIT, Inc. / Baller Lance Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13D/A-2 Under the Securities Exchange Act of 1934 (Amendment No. |
|
August 27, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission F |
|
August 27, 2018 | ||
August 13, 2018 |
8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporat |
|
August 13, 2018 |
GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact name |
|
June 27, 2018 |
GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report) 10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE R |
|
May 15, 2018 |
GBCS / Global Healthcare REIT, Inc. NT 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2018 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I—Re |
|
May 10, 2018 |
GLOBAL HEALTHCARE REIT, INC. NOTICE OF GRANT OF STOCK OPTION Notice is hereby given of the following option grant (the “Option”) to purchase shares of the Common Stock of Global Healthcare REIT, Inc., a Utah corporation (the “Company”): OPTIONEE: ZVI RHINE GRANT DATE: APRIL 1 2018, VESTING COMMENCEMENT DATE: APRIL 1, 2018 EXERCISE PRICE: $0.36 PER SHARE NUMBER OF OPTION SHARES: 600,000 SHARES OF C |
|
May 10, 2018 |
Restricted Stock Award Agreement AGREEMENT FOR RESTRICTED STOCK AWARD THIS AGREEMENT FOR RESTRICTED STOCK AWARD is made and entered into effective 1st day of April, 2018, by and between GLOBAL HEALTHCARE REIT, INC. |
|
May 10, 2018 |
GLOBAL HEALTHCARE REIT, INC. NON-QUALIFIED STOCK OPTION AGREEMENT This Non-Qualified Stock Option Agreement (the “Agreement”) is attached as Exhibit A to a Notice of Grant of Stock Option (the “Grant Notice”), pursuant to which Optionee has been informed of the basic terms of the option evidenced thereby. Certain capitalized terms used but not otherwise defined herein have the respective meanings |
|
May 10, 2018 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File |
|
May 10, 2018 |
EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) made and entered into this 1st day of April, 2018, to be effective as of the 1st day of January, 2018 (the “Effective Date”), by and between GLOBAL HEALTHCARE REIT, a Utah corporation (the “Company”) and ZVI RHINE (the “Executive”). |
|
May 10, 2018 |
GBCS / Global Healthcare REIT, Inc. / Rhine Zvi Michael Activist Investment SC 13D 1 formsc13d.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* GLOBAL HEALTHCARE REIT, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 37953J 10 7 (CUSIP Number) Clifford L. Neuman, PC 6800 N. 79th Street, Suite 200 Niwot, Colorado 80503 (303) 449 – 2100 (Name, Address, and Tele |
|
April 24, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
April 24, 2018 | ||
April 24, 2018 |
GBCS / Global Healthcare REIT, Inc. 10-K (Annual Report) 10-K 1 form10-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE R |
|
April 17, 2018 |
PURCHASE AND SALE AGREEMENT THIS PURCHASE AND SALE AGREEMENT (this “Agreement”) is made by and between MIDWAY NIMITZ, LLC, a Georgia limited liability company (“Purchaser”) and GORDON JENSEN HEALTH CARE ASSOCIATION, INC. |
|
April 17, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fil |
|
March 29, 2018 |
GBCS / Global Healthcare REIT, Inc. NT 10-K U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ X ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2017 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part |
|
January 23, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2018 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
January 23, 2018 |
GBCS / Global Healthcare REIT, Inc. / Park City Capital, LLC - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Under the Securities Exchange Act of 1934 (Amendment No. |
|
November 20, 2017 |
GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Sm |
|
November 16, 2017 |
SERIES 2017 10% SENIOR PROMISSORY NOTE DUE OCTOBER 31, 2020 EX-99.1 3 ex99-1.htm THIS NOTE HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN |
|
November 16, 2017 |
Form of Agreement Among Lenders AGREEMENT BY AND AMONG LENDERS This Agreement is made and entered into as of the day of , 2017, by and between Global Healthcare REIT, Inc. |
|
November 16, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer o |
|
November 14, 2017 |
GBCS / Global Healthcare REIT, Inc. 0-Q U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-SAR For Period Ended: September 30, 2017 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part |
|
November 6, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer o |
|
November 6, 2017 | ||
November 6, 2017 |
EX-10.1 2 ex10-1.htm |
|
November 6, 2017 |
Credit Note – Southern Tulsa, LLC and Southern Tulsa TLC, LLC EX-10.3 4 ex10-3.htm |
|
October 17, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |
|
September 11, 2017 |
GBCS / Global Healthcare REIT, Inc. / Baller Lance Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13D/A-1 Under the Securities Exchange Act of 1934 (Amendment No. |
|
August 21, 2017 |
GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Small B |
|
August 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
August 14, 2017 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-SAR For Period Ended: June 30, 2017 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I?Reg |
|
June 14, 2017 |
GBCS / Global Healthcare REIT, Inc. 10-Q (Quarterly Report) 10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ X ] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC. |
|
May 16, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission File (I.R.S. Employer |
|
May 16, 2017 | ||
May 15, 2017 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [x] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2017 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I?Re |
|
May 5, 2017 |
Allonge and Modification Agreement ALLONGE AND MODIFICATION AGREEMENT This ALLONGE AND MODIFICATION AGREEMENT (“Modification”) is entered into this 3rd day of May, 2017, by and between the undersigned (“Lender”); and GOODWILL HUNTING, LLC, a Georgia limited liability company (“Borrower”); RECITALS A. |
|
May 5, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer of inc |
|
April 28, 2017 |
Global Healthcare REIT (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0-15415 GLOBAL HEALTHCARE REIT, INC . (Exact na |
|
April 7, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fil |
|
March 31, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A-1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commissio |
|
March 21, 2017 |
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 SEC File Number 0-15415 CUSIP Number 37953J107 NOTICE OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2016 If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A Part I |
|
March 15, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission Fi |
|
January 30, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction Commission (I.R.S. Employer o |
|
January 26, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2017 GLOBAL HEALTHCARE REIT, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission |